This inventor holds 1 USPTO granted patent. Top assignee: Hitachi Chemical Company, Ltd.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Tomohiro Yamaguchi: Innovator in Urinary Treatment
Introduction
Tomohiro Yamaguchi is a notable inventor based in Hitachi, Japan. He has made significant contributions to the field of medical treatments, particularly in addressing urinary obstruction. His innovative approach has led to the development of a therapeutic agent that holds promise for patients suffering from this condition.
Latest Patents
Yamaguchi holds a patent for a method for treating urinary obstruction. The patent, titled "6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl)propyl]-amino]-1,3-dimethyluracil," outlines a novel therapeutic agent that can be utilized in the treatment of urinary obstruction. This invention showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Tomohiro Yamaguchi is associated with Hitachi Chemical Company, Ltd., where he has been instrumental in research and development efforts. His work has not only contributed to the company's portfolio but has also enhanced the understanding of urinary health and treatment options.
Collaborations
Yamaguchi has collaborated with esteemed colleagues, including Masayuki Ishikawa and Shigeru Ito. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in medical treatments.
Conclusion
Tomohiro Yamaguchi's contributions to the field of urinary treatment exemplify the impact of dedicated inventors in healthcare. His patent for a method addressing urinary obstruction highlights the importance of innovation in improving patient care. Through his work at Hitachi Chemical Company, Ltd., Yamaguchi continues to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile